Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Compare the clinical characteristics and post-surgical outcomes (overall survival)of pancreatic cancer patients of Ashkenazi descent with or without germline founder mutations in BRCA1 or BRCA2 .
Compare the clinical characteristics and outcomes (time to progression) of breast cancer patients of Ashkenazi descent with or without germline founder mutations in BRCA1 or BRCA2 receiving paclitaxel chemotherapy for metastatic disease.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Included in DB0363-03
Jewish religious preference at registration
Archival material available for testing
Adequate post-surgical follow-up
Jewish religious preference at registration
Archival material available for testing
Adequate follow-up to determine time to progression
You may not be if
Subjects will not be included in the analyses if a DNA sample cannot be obtained.
